[1]
2025. Discontinuity of Sacubitril/Valsartan in a Cohort of Hospitalised Individuals for Heart Failure. Epidemiology, Biostatistics, and Public Health. (Sep. 2025). DOI:https://doi.org/10.54103/2282-0930/29594.